Arrowhead Research reported $25.09M in Current Liabilities for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Anika Therapeutics ANIK:US $ 31.14M 3.23M
Arrowhead Research ARWR:US $ 25.09M 15.59M
Cerulean Pharma CERU:US $ 7.96M 1.88M
Heron Therapeutics HRTX:US $ 102.5M 4.92M
Ligand Pharmaceuticals LGND:US $ 100.11M 57.81M
Opko Health OPK:US $ 375.48M 39.59M
Sarepta Therapeutics SRPT:US $ 378.39M 23.49M
Spectrum Pharmaceuticals SPPI:US $ 61.1M 5.54M
Tg Therapeutics TGTX:US $ 77.67M 10.13M
Ultragenyx Pharmaceutical RARE:US $ 189.61M 11.58M
Vertex Pharmaceuticals VRTX:US $ 1877.53M 126.49M
Xencor XNCR:US $ 121.06M 50.57M